HOME COMPANY OUR VALUE PROJECTS NEWS EVENTS ABOUT MEDSIR CONTACT US! Strategic Trial Design The initial spark that sets off our clinical trial design process is a bright idea that comes to us from the strong mind of a Medical Oncologist. Then, thanks to MedSIR’s innovative set-up, these ideas are transformed into strategic clinical trials that contemplate patient benefit, scientific advance, and efficient drug development. Today, over 200 ideas now populate our Intellectual Pipeline and involve some of the newest and most impactful drugs on the market -or currently in development- such as pertuzumab, olaparib, niraparib, T-DM1, palbociclib, neratinib, osimertinib, RAD-223, pembrolizumab, atezolizumab, and many more. A few key factors help us to go from initial idea to the set-up of a successful clinical trial: 1. We understand current and future market trends, which enables us to design coherent and relevant trials not only thinking about today, but also, our patients of tomorrow. 2. Our quick and flexible approach allows us to work efficiently and adapt our trials to your CDPs, company policies and strategies, finding win-win situations for both parties. 3. Our expert team is at the forefront of its domain and strives to draw up the best strategies that are both clinically and scientifically relevant. «We design our studies synergistically with our clients thanks to sharing a common goal: improving the lives of our patients and their families» OUR CONTINUOUSLY GROWING TEAM OF IDEA GENERATORS JOSE PEREZ JOAN CARLES DAVID PAEZ NOEMÍ REGUART JOAN MAUREL JOSEP MARÍA PIULATS PETER SCHMID ESTHER HOLGADO JOSEPH GILGOROV FREDERIK MARMÉ SHAREEF ELSAMANY ANDRÉS POVEDA NIKI KARACHALIOU IGNACIO ROMERO JOSÉ ENRIQUE ALÉS ELENA AGUIRRE JAVIER GARDE HOW WE OPTIMIZE YOUR CDP Since its creation, MedSIR has carried out projects in metastatic breast cancer, endometrial cancer, and lung cancer, while in the process of designing trials for a number of other tumors such as prostate and ovarian. In the near future, the MedSIR concept will allow to expand into other pathologies and diseases. HELPING PATIENTS WORLDWIDE 1.181 patients SUCCESSFULLY ENROLLED FOLLOW US ON TWITTER FEED Follow @medsir2012 MedSIR @medsir2012 2 days ago Rachael Bland, BBC presenter and cancer blogger, reveals she has just 'days left to live' https://t.co/z8W6f1jMlC via @telegraphnews #Cancer View on Twitter MedSIR @medsir2012 2 days ago 😐☹️😭 https://t.co/0rSs0bnn6Z View on Twitter RadioToday UK @RadioToday Devastating news as 5 live's Rachel Bland shares that she has just days left to live https://t.co/PBsMiKgQaq https://t.co/xFfQRlSD5V INSTAGRAM FEED Follow us on Instagram FACEBOOK FEED MedSIR It is a great pleasure to welcome you to MedSIR, a private company founded by Oncology experts in 2012. Together, not only we do make up an international team with many years of high-level clinical and research experience, but also, and even more importantly, a team that is passionate about helping you, our clients, to get your best and most innovative treatments to our patients as efficiently and quickly as possible. Along the way, we strive to improve our scientific knowledge of this complex disease and the large array of available treatments, producing a win-win-win situation for your company, for our patients, and for the scientific community. This endeavor requires strong and creative minds to generate novel, out-of-the-box ideas, as well as a high-level operations team behind the scenes that brings these strategic ideas to life. At MedSIR we have the complete package that is changing the way IIS Research is being done. Bring your idea to life💡 Design & Management of Clinical Trials 📊 Medica Scientia Innovation Research (MedSIR) MedSIR15 hours ago Dicen que la ciencia arruina toda la diversión y esta semana, nuevamente se fueron en contra de uno de los pasatiempos favoritos de la gente: comer dulces. #Oncología #Cáncer #Berlines #Dulces Coman tranquilos: La verdad acerca del cáncer y los berlines . mouse.latercera.com 3 View on Facebook MedSIR2 days ago Las células transportan virus oncolíticos que son capaces de destruir células cancerígenas del tumor del paciente. https://www.20minutos.es/noticia/3430043/0/un-caballo-troya-luchar-contra-el-cancer/ #Oncología #Cáncer #Investigación Celyvir, la novedosa terapia para luchar contra el cáncer Investigadores españoles están trabajando en una novedosa terapia, registrada como 'Celyvir', que actúa como una especie de 'caballo de Troya' para... 20minutos.es 34 View on Facebook FOLLOW US ON COMPANY · Welcome · Our Vision · The MedSIR Team · From Barcelona… OUR VALUE · Scientific Board · Strategic Trial Design · Idea Submission · Commitment to Quality PROJECTS · Current Projects · Closed Projects · Publications · #medsireverywhere NEWS & EVENTS · News · Events ABOUT · FAQ · Testimonials · Contact Us! GET OUR MONTHLY NEWSLETTER! First name: Last name: Email address: Before you sign the application, you should read the basic information on data protection listed here I accept the sending of periodic commercial communications by MEDICA SCIENTIA INNOVATION RESEARCH, SL Please choose your area of interest: Healthcare/Academic Professional Pharma/Biotech Professional Other Companies Action to perform: Subscribe Unsubscribe © 2018 MedSIR | Privacy Policy | Legal Notice | Official Notice | Cookie Policy | info@medsir.org We'll assume you're ok with this, but you can opt-out if you wish.Accept